Overview

The Priority-driven Collaborative Cancer Research Scheme is an innovative annual national research project grants funding scheme which brings together government and other funders to collaboratively fund cancer research in Australia.

This funding scheme helps to:

• coordinate funding of priority-driven cancer research at the national level,
• foster collaboration between cancer researchers to build Australia’s cancer research capacity, and
• foster consumer participation in cancer research, from design to implementation.

Working with the National Health and Medical Research Council (NHMRC)

This research scheme is managed by Cancer Australia and the agency collaborates with NHMRC in this grant scheme. NHMRC facilitates registration and initial assessment of applications, and endorses grants funded through this scheme in recognition of their scientific merit.

 

Successful applicants in the 2022 Round

On 15 December 2022, the Australian Government announced successful applicants in the 2022 round of the Priority-driven Collaborative Cancer Research Scheme, proudly supported by Cancer Australia, Australian Lions Childhood Cancer Research Foundation, Can Too Foundation, Leukaemia Foundation, Lung Foundation Australia, My Room Children’s Cancer Charity Ltd, and The Kids’ Cancer Project.
 

Successful grants in the 2022 PdCCRS round are as follows:

Aoude, Lauren

Diamantina Institute, The University of Queensland

Radiomics analysis to improve outcomes for melanoma patients

Funded by: Cancer Australia

Brims, Fraser

Curtin University

Improving lung cancer care: the lung cancer clinical quality data platform (LUCAP)

Funded by: Cancer Australia and Lung Foundation Australia

Da Gama Duarte, Jessica

Olivia Newton-John Cancer Research Institute, La Trobe University

Early detection, diagnosis, and prognosis of lung cancers

Funded by: Cancer Australia and Lung Foundation Australia

Gargett, Tessa

Royal Adelaide Hospital, Central Adelaide Local Health Network Incorporated

Targeting the DC-T cell axis to treat glioblastoma

Funded by: Cancer Australia and The Kids’ Cancer Project

Gunawardana, Jithendra

Translational Research Institute, The University of Queensland

Harnessing the tumour microenvironment to stratify and treat nodular lymphocyte predominant Hodgkin Lymphoma

Funded by: Leukaemia Foundation

Lawrence, Mitchell

Monash University

Boosting PSMA levels in prostate cancer

Funded by: Cancer Australia

Panagopoulos, Vasilios

The University of Adelaide

Targeted inhibition of myeloperoxidase (MPO): A new therapeutic strategy to prevent multiple myeloma disease progression

Funded by: Cancer Australia, Can Too Foundation, and Leukaemia Foundation

Parker, Amelia

Garvan Institute of Medical Research, University of New South Wales

Targeting the CTHRC1-Wnt axis as a precision medicine approach in squamous lung cancer

Funded by: Cancer Australia

Sieber, Oliver

The Walter and Eliza Hall Institute of Medical Research

Personalising first-line treatment for patients with metastatic colorectal cancer

Funded by: Cancer Australia

Somers, Klaartje

Children’s Cancer Institute, University of New South Wales

Targeting NAD metabolism to overcome therapeutic resistance in adult and paediatric acute myeloid leukaemia

Funded by: Cancer Australia, Australian Lions Childhood Cancer Research Foundation, My Room Children’s Cancer Charity Limited, and The Kids’ Cancer Project

Tobin, Joshua

Mater Research Institute, The University of Queensland

The Role of Lipids in the Immune Fitness of Malignant B cells, Intratumoral T cells and CAR-T cells in Follicular Lymphoma

Funded by: Cancer Australia and Can Too Foundation

Webb, Penelope

The Council of the Queensland Institute of Medical Research

Linking routine health data to investigate variation and inequality in care and survival to Improve outcomes for women with cervical, uterine, vaginal and vulvar cancer in Australia

Funded by: Cancer Australia

Yim, Howard Chi Ho

Microbiome Research Centre, University of New South Wales

A Novel Probiotic as a preventive strategy for Colorectal Neoplasia

Funded by: Cancer Australia

Cancer Australia's funding partners and the successful applicants in the PdCCRS rounds of:

2022

• Successful applicants for 2022 round (PDF)
• Successful applicants for 2022 round (DOC)

2021

• Successful applicants for 2021 round (PDF)
• Successful applicants for 2021 round (DOC)

2020

• Successful applicants for 2020 round (PDF)
• Successful applicants for 2020 round (DOC)

2019

• Successful applicants for 2019 round (PDF)
• Successful applicants for 2019 round (DOC)

2018

• Successful applicants for 2018 round (PDF)
• Successful applicants for 2018 round (DOC)

2017

• Successful applicants for 2017 round (PDF)
• Successful applicants for 2017 round (DOC)

2016

• Successful applicants for 2016 round (PDF)
• Successful applicants for 2016 round (DOC)

2015

• Successful applicants for 2015 round (PDF)
• Successful applicants for 2015 round (DOC)

2014

•  Successful applicants for 2014 round (PDF)
•  Successful applicants for 2014 round (DOC)

2013

• Successful applicants for 2013 round (PDF) 
• Successful applicants for 2013 round (DOC)

2012

• Successful applicants for 2012 round (PDF) 
• Successful applicants for 2012 round (DOC)

2011

• Successful applicants for 2011 round (PDF)
• Successful applicants for 2011 round (DOC)

2010

• Successful applicants for 2010 round (PDF)
• Successful applicants for 2010 round (DOC )

2009

• Successful applicants for 2009 round (PDF)
• Successful applicants for 2009 round (DOC )

2008

• Successful applicants for 2008 round (PDF)
• Successful applicants for 2008 round (DOC )

2007

• Successful applicants round 2007 (PDF)
• Successful applicants round 2007 (DOC)
   

Find out more about:

• Download Priority-driven Collaborative Cancer Research Scheme fact sheet (DOC 26 KB) 
• Consumer participation in research Grant Review Committees